Pushpa Narayanaswami, MD

Article

Myasthenia Gravis Highlights From AANEM 2024

Author:: Pushpa Narayanaswami, MD

Publish date: November 7, 2024

Highlights in myasthenia gravis from AANEM 2024 include efficacy data on efgartigimod, ravulizumab, zilucoplan, and first-in-class inebilizumab, as...